Search

Your search keyword '"Roos S"' showing total 460 results

Search Constraints

Start Over You searched for: Author "Roos S" Remove constraint Author: "Roos S" Search Limiters Full Text Remove constraint Search Limiters: Full Text
460 results on '"Roos S"'

Search Results

1. Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trial

2. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

3. The short- and longer-term effects of brief behavioral parent training versus care as usual in children with behavioral difficulties: study protocol for a randomized controlled trial

4. Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol

5. Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

6. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study

8. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

10. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study

11. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

12. Functional outcomes in symptomatic versus asymptomatic patients undergoing incisional hernia repair: Replacing one problem with another? A prospective cohort study in 1312 patients

13. First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

15. Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

17. ALL-tRNAseq enables robust tRNA profiling in tissue samples

19. Fabricated Flips: Poisoning Federated Learning without Data

20. A Deployment-First Methodology to Mechanism Design and Refinement in Distributed Systems

21. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON):results from the direct boost group of an open-label, multicentre, randomised controlled trial

22. Maverick Matters: Client Contribution and Selection in Federated Learning

23. Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19:A Nationwide Observational Cohort Study*

24. Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients with COVID-19: A Nationwide Observational Cohort Study∗

25. Response to immune checkpoint inhibitors in acral melanoma

26. Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

27. ALL-tRNAseq enables robust tRNA profiling in tissue samples

29. Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol

31. No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study

32. In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival

33. First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis

34. Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

35. Correction:First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis (British Journal of Cancer, (2021), 124, 7, (1222-1230), 10.1038/s41416-020-01229-1)

36. HBSC 2021. Gezondheid en welzijn van jongeren in Nederland

37. HBSC 2021. Gezondheid en welzijn van jongeren in Nederland

38. Topology Inference of Networks utilizing Rooted Spanning Tree Embeddings

39. Response to immune checkpoint inhibitors in acral melanoma:A nationwide cohort study

40. Crack detection for dikes using distributed temperature sensing

41. First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis

42. Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study

43. Psychosocial functioning in adolescents growing up with chronic disease: The Dutch HBSC study

47. Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19

48. Serum Calcification Propensity and the Risk of Cardiovascular and All-Cause Mortality in the General Population

49. Nitric oxide and long-term outcomes after kidney transplantation: Results of the TransplantLines cohort study

Catalog

Books, media, physical & digital resources